PRIMA-1MET (APR-246), a reactivator of mutant p53, has been reported to promote autophagy and apoptosis in CRC cells via the mTOR/AMPK-ULK1-Vps34 signaling pathway, highlighting its relevance in p53-mutant tumors (65). Here, ULK1 is linked to colorectal carcinoma.